| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Foghorn Therapeutics Inc. | Chief People Officer | Stock Option (right to buy) | 115K | $503K | $4.37 | Jan 22, 2025 | Direct |
| Foghorn Therapeutics Inc. | Chief People Officer | Common Stock | 0 | $0 | $10.17 | Sep 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc. | Jan 22, 2025 | 1 | $503K | 4 | Jan 24, 2025 | Chief People Officer |
| FHTX | Foghorn Therapeutics Inc. | Sep 20, 2024 | 6 | -$232K | 4 | Sep 24, 2024 | Chief People Officer |
| FHTX | Foghorn Therapeutics Inc. | Sep 18, 2024 | 3 | -$73.3K | 4 | Sep 20, 2024 | Chief People Officer |
| FHTX | Foghorn Therapeutics Inc. | Sep 16, 2024 | 6 | -$67.4K | 4 | Sep 18, 2024 | Chief People Officer |
| FHTX | Foghorn Therapeutics Inc. | Jan 24, 2024 | 1 | $275K | 4 | Jan 25, 2024 | Chief People Officer |
| FHTX | Foghorn Therapeutics Inc. | Jan 26, 2023 | 1 | $0 | 4 | Jan 30, 2023 | Chief People Officer |
| FHTX | Foghorn Therapeutics Inc. | Aug 1, 2022 | 0 | $0 | 3/A | Sep 9, 2022 | Chief People Officer |
| FHTX | Foghorn Therapeutics Inc. | Aug 1, 2022 | 1 | $0 | 4 | Aug 3, 2022 | Chief People Officer |